ReWalk Receives CE Mark For ReStore Exo-Suit For Stroke Rehabilitation
Executive Summary
Israel-based exoskeleton company ReWalk Robotics Ltd. announced it received a CE mark for its next-gen ReStore Exo-Suit for stroke rehabilitation, paving the way into a larger patient population.
You may also be interested in...
ReWalk Robotics’ Planned Acquisition Of Anti-Gravity Maker AlterG For $19M Paves Way To Profitability
ReWalk Robotics’ planned $19m acquisition of AlterG will put ReWalk on the path to profitability and positive cash flow, creating a combined company with trailing 12-month revenues of about $26m.
ReWalk Plans $40M Private Placement To Fund Marketing, R&D Of Exoskeletons
ReWalk plans to use the proceeds to fund sales, R&D and reimbursement expenses related to its ReStore and Personal 6.0 devices as it continues to face negative effects of pandemic.
Lawyers: Securities Suits Among Life Sciences Firms Down In 2020 – But Don’t Expect Trend To Last
Attorneys with the law firm Dechert LLP expect the number of securities claims filed to rise in 2021 after a slide last year.